Treatment Outcomes in Patients with Recurrent Adrenocortical Carcinoma
A significant proportion of patients with ACC recurrence experience disease progression or second recurrence, despite all treatment efforts. Nevertheless, by integrating diverse treatment modalities, many patients have the potential to attain long-term survival.
Authors
- Karin Zibar (ORCID: https://orcid.org/0000-0002-1694-6891)
- Ivana Dora Vodanović (ORCID: https://orcid.org/0000-0002-5380-4411)
- Ana Marija Alduk (ORCID: https://orcid.org/0000-0002-5438-4439)
- Ivana Kraljević (ORCID: https://orcid.org/0000-0002-4379-2250)
- Tanja Škorić Polovina (ORCID: https://orcid.org/0000-0003-3785-6657)
- Anja Barač Nekić (ORCID: https://orcid.org/0000-0003-2672-8529)
- Zrna Antunac Golubić (ORCID: https://orcid.org/0000-0003-3914-7600)
- Tina Dušek (ORCID: https://orcid.org/0000-0002-1266-3501)
- Nikola Knežević (ORCID: https://orcid.org/0000-0001-9198-310X)
- Tamara Dojčinović (ORCID: https://orcid.org/0009-0007-1183-8940)
- Darko Kaštelan (ORCID: https://orcid.org/0000-0003-3034-5598)
Institutions
- University Hospital Centre Zagreb (HR)
- University of Banja Luka (BA)
- University of Zagreb (HR)
- University Clinical Centre (PL)
- University clinical center of Republika Srpska (BA)
Publication Details
- Journal
- Endocrine Research
- Published
- 2024-09-02
- DOI
- https://doi.org/10.1080/07435800.2024.2397561
- Citations
- 1
- Primary Topic
- Adrenal and Paraganglionic Tumors
- Type
- article
- Field-Weighted Citation Impact
- 0.57